UNICREDIT BANK/CALL/MERCK/160/0.1/19.03.25 Stock

Warrant

DE000HD4VZ87

Real-time BOERSE MUENCHEN 02:00:27 2024-07-18 am EDT
1.26 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/MERCK/160/0.1/19.03.25
Current month-10.64%
1 month-50.39%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-18 1.26 0.00%
24-07-17 1.26 +2.44%
24-07-16 1.23 +6.96%
24-07-15 1.15 -7.26%
24-07-12 1.24 +0.81%

Real-time BOERSE MUENCHEN

Last update July 18, 2024 at 02:00 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD4VZ8
ISINDE000HD4VZ87
Date issued 2024-04-22
Strike 160
Maturity 2025-03-19 (245 Days)
Parity 10 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.78
Lowest since issue 0.98
Spread 0.11
Spread %8.33%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
154.6 EUR
Average target price
181.4 EUR
Spread / Average Target
+17.40%
Consensus